Skip to content
PSPeptide
Student
Join free
LibraryCoursesField NotesAboutJoin
← Peptide Library
Identity unresolved / not FDA-approved

PT-10

Identity unresolved — no invented CID/CAS/sequence; ≠ PT-141; TP10 is name-collision context only.

Editorial review:
What evidence says

Evidence snapshot

This drawer marks papers. It is not a plan, a dose, or a source. A paper is a bounded report. It is not a protocol. Grades name the object. They are not a safety rating.

Identity lock. PT-10 could not be locked to a single, unambiguous peptide object from PubMed / PubChem in this pass. Shop-checklist labeling alone is not identity. Candidate collisions seen in open literature (e.g. transportan-10 / TP10 cell-penetrating peptide, CAS often cited 203716-10-3) are not accepted as proven for this label without sequence confirmation. PT-10 ≠ PT-141 (bremelanotide; separate drawer). PT-10 ≠ PT-20 (also unresolved). PubChem CID / formula / CAS: To be confirmed. This drawer marks the identity gap. It is not use advice.

Bottom line

Identity unresolved. Few or no object-matched PMIDs can be graded until sequence / CAS / CID are confirmed. Do not invent a drawer identity from adjacent “PT-” names.

Papers

No object-matched Primary papers are graded in this pack. If a future identity lock points to transportan-10 / TP10, that would be a new evidence pass with CPP membrane papers — not implied here.

Adjacent name collision (not graded as PT-10 proof)

PMID 37634858 — Bennett 2023

Tested: molecular-dynamics study of cell-penetrating peptide transportan-10 (TP10) membrane binding/insertion.

Does not show: that shop label “PT-10” is TP10; included only as a documented name-collision reminder.

What is not established

Any locked chemical identity for PT-10. Any human clinical efficacy. Equivalence to PT-141, PT-20, or transportan-10 without analytical confirmation. This drawer does not provide use advice, schedules, or sourcing.

Selected sources

37634858

What people discuss

Reported experiences

Reported topics are not established benefits.
Watch for

Risks and unknowns

Context matters. Approval of one medicine, formulation, or use does not establish approval of products sold online or other uses. This page is educational and does not provide dosing or treatment advice.
Member discussion

Compare experiences with care.

Before posting: Describe firsthand observations and uncertainty. Do not prescribe, arrange transactions, or post private health information.
◎Verified members

Join the discussion

Verified members can contribute to compound conversations.

No approved member reports yet. Thoughtful first contributions are welcome.